Neurotransmitters: Roles, Functions, and Impact on Mental Health

Key takeaways

• Neurotransmitters are chemical messengers that enable communication between neurons, regulating a wide range of physiological and psychological processes.
• Major types of neurotransmitters include amino acids (glutamate, GABA), monoamines (serotonin, dopamine), peptides (endorphins), and acetylcholine.
• Neurotransmitter imbalances are implicated in various mental health disorders, such as depression, anxiety, schizophrenia, and Parkinson's disease.
• Medications that target neurotransmitter systems, such as SSRIs for depression, are commonly used to treat these disorders.
• Ongoing research aims to develop more personalized treatments, identify novel drug targets, and elucidate the relationship between neurotransmitters and the gut-brain axis.
• While neurotransmitter imbalances are associated with mental health conditions, a holistic approach addressing biological, psychological, and environmental factors is often most effective.

Introduction to Neurotransmitters

Neurotransmitters are the unsung heroes of our nervous system, serving as the chemical messengers that enable communication between neurons. These microscopic molecules play a crucial role in transmitting signals across synapses, the tiny gaps between nerve cells.

Without neurotransmitters, our brains and bodies would be unable to function properly, as they are essential for everything from controlling our movements to regulating our emotions.

In the complex network of our nervous system, neurons are constantly sending and receiving signals. When a neuron is activated, it releases neurotransmitters into the synapse. These chemicals then bind to specific receptors on the receiving neuron, either exciting or inhibiting it. 

This process allows for the rapid transmission of information throughout the nervous system, enabling us to think, feel, and act. The discovery of neurotransmitters revolutionized our understanding of brain function and paved the way for significant advancements in neuroscience and psychiatry. 

As we delve deeper into the world of these chemical messengers, we'll explore their diverse functions, types, and the profound impact they have on our mental health.

What is the Function of Neurotransmitters?

Neurotransmitters serve a multitude of functions in both the brain and body, acting as the primary means of communication within the nervous system. Their roles are diverse and far-reaching, influencing nearly every aspect of our physiological and psychological functioning.

The primary function of neurotransmitters is to transmit signals from one neuron to another across synapses. This process is fundamental to neural communication and is the basis for all brain activity.

When a neurotransmitter binds to a receptor on a target neuron, it can either excite the neuron, making it more likely to fire an action potential or inhibit it, making it less likely to fire.

Beyond this basic signalling function, neurotransmitters play critical roles in:

1. Regulating mood and emotions: Neurotransmitters like serotonin and dopamine are closely linked to our emotional states and can influence feelings of happiness, sadness, anxiety, and motivation. Research indicates that serotonin levels can affect mood regulation, with low levels being associated with depression.
2. Controlling motor function: Acetylcholine and dopamine, among others, are crucial for coordinating muscle movements and maintaining balance. For instance, dopamine deficiency is a hallmark of Parkinson's disease, leading to motor control issues.
3. Modulating sleep-wake cycles: Neurotransmitters such as melatonin and norepinephrine help regulate our circadian rhythms and sleep patterns. Melatonin, produced by the pineal gland, plays a significant role in signalling sleep onset.
4. Managing pain perception: Endorphins, which are peptide neurotransmitters, act as natural painkillers in the body. Studies show that endorphin release can significantly reduce the perception of pain during stressful situations.
5. Regulating appetite and digestion: Neurotransmitters like serotonin play a role in controlling hunger signals and digestive processes. Approximately 90% of the body's serotonin is found in the gastrointestinal tract, influencing gut motility and appetite.
6. Influencing memory and learning: Acetylcholine and glutamate are particularly important for cognitive functions, including memory formation and recall. Glutamate is the most abundant excitatory neurotransmitter in the brain, essential for synaptic plasticity, which underpins learning.
7. Maintaining heart rate and blood pressure: Norepinephrine helps regulate cardiovascular function, increasing heart rate and blood pressure during stress.
8. Controlling hormone release: Some neurotransmitters interact with the endocrine system to influence hormone production and release. For example, norepinephrine can stimulate the adrenal glands to release adrenaline during stress.

The function of neurotransmitters is not limited to a single action; many of these chemical messengers have multiple roles depending on where in the nervous system they are released and which receptors they interact with. This versatility allows for complex and nuanced control of various bodily functions and mental processes.

Role of Neurotransmitters in the Brain

In the brain, neurotransmitters play an indispensable role in shaping our thoughts, emotions, and behaviours. Their influence extends to every aspect of brain function, from basic survival instincts to complex cognitive processes.

One of the most crucial roles of neurotransmitters in the brain is mood regulation. Serotonin, often referred to as the "feel-good" neurotransmitter, helps regulate mood, anxiety, and happiness. Low levels of serotonin are associated with depression, while balanced levels contribute to a sense of well-being.

Studies show that individuals with depression often have lower serotonin levels, leading to the development of selective serotonin reuptake inhibitors (SSRIs) as a common treatment option.

Dopamine, another key neurotransmitter, is involved in the brain's reward system, influencing motivation, pleasure, and reinforcement of behaviours.

Research indicates that dopamine release is linked to feelings of pleasure and satisfaction, reinforcing behaviours that are essential for survival. Dysregulation of dopamine pathways is implicated in addiction, where individuals may seek substances that artificially elevate dopamine levels.

Cognition is another area heavily influenced by neurotransmitters. Acetylcholine, for instance, is vital for attention, learning, and memory formation. It plays a significant role in the encoding of new memories and the retrieval of stored information.

Glutamate, the most abundant excitatory neurotransmitter in the brain, is crucial for cognitive functions such as learning and memory consolidation.

Neurotransmitters also play a key role in regulating sleep and wakefulness. GABA (gamma-aminobutyric acid), the main inhibitory neurotransmitter in the brain, promotes relaxation and sleep.

On the other hand, norepinephrine and orexin promote wakefulness and alertness. Research indicates that GABA levels can significantly impact sleep quality and duration.

The impact of neurotransmitters on behaviour is profound. They influence everything from our eating habits to our social interactions.

For example, oxytocin, sometimes called the "love hormone," is involved in social bonding and trust. Meanwhile, dopamine plays a role in addictive behaviours by reinforcing pleasurable activities.

Neurotransmitters are also crucial in the brain's stress response. When we encounter a stressful situation, neurotransmitters like norepinephrine and cortisol (which, while primarily a hormone, can also act as a neurotransmitter) are released, triggering the "fight or flight" response.

The balance of neurotransmitters in the brain is delicate, and even small disruptions can have significant effects on mental health.

Imbalances in neurotransmitter levels or function are implicated in various mental health disorders. For instance:

• Depression is often associated with low levels of serotonin and norepinephrine.
• Anxiety disorders may involve an overactive glutamate system or an underactive GABA system.
• Schizophrenia is linked to irregularities in dopamine signalling.
• ADHD is thought to involve imbalances in dopamine and norepinephrine.

Understanding the role of neurotransmitters in the brain has revolutionized our approach to mental health treatment. Many psychiatric medications work by altering neurotransmitter levels or their interactions with receptors.

For example, SSRIs increase the availability of serotonin in the brain and are commonly used to treat depression and anxiety disorders.

With breakthroughs in neuroscience research, our understanding of the complex roles neurotransmitters play in brain function continues to expand, opening new avenues for treating mental health disorders and improving overall brain health.

Types of Neurotransmitters and Examples

Neurotransmitters can be categorized into several types based on their chemical structure and function. 

Let's explore the main types and some key examples:

Amino Acids

Amino acid neurotransmitters are derived from simple amino acids and play crucial roles in fast synaptic transmission.

1. Glutamate: The most abundant excitatory neurotransmitter in the brain, glutamate is crucial for learning, memory, and synaptic plasticity. It's involved in the brain's ability to form new neural connections and adapt to new experiences.
2. GABA (Gamma-Aminobutyric Acid): As the primary inhibitory neurotransmitter in the brain, GABA plays a vital role in reducing neuronal excitability. It promotes relaxation, reduces anxiety, and helps regulate muscle tone. Research shows that GABA levels can significantly impact anxiety disorders.
3. Glycine: Another inhibitory neurotransmitter, glycine is most prevalent in the spinal cord and brainstem. It's important for motor and sensory functions and also plays a role in the processing of auditory and visual information.

Monoamines

Monoamines are derived from aromatic amino acids and have wide-ranging effects on mood, arousal, and cognitive functions.

1. Serotonin: Often associated with feelings of well-being and happiness, serotonin plays a crucial role in mood regulation, sleep, appetite, and digestion. It's a primary target for many antidepressant medications. Studies have shown that increasing serotonin levels can alleviate symptoms of depression.
2. Dopamine: Known as the "reward neurotransmitter," dopamine is involved in motivation, pleasure, and reinforcement learning. It's also crucial for motor control and is implicated in disorders like Parkinson's disease and addiction. Research indicates that dopamine dysregulation can lead to compulsive behaviours.
3. Norepinephrine: This neurotransmitter is involved in the body's stress response, increasing alertness and arousal. It plays a role in attention, emotions, sleeping, dreaming, and learning.
4. Epinephrine (Adrenaline): While primarily a hormone, epinephrine can also act as a neurotransmitter. It's crucial in the "fight or flight" response, increasing heart rate, blood pressure, and energy supplies.

Peptides

Peptide neurotransmitters are short chains of amino acids that often have neuromodulatory effects.

1. Endorphins: These natural painkillers are produced by the body in response to stress or pain. They're responsible for the "runner's high" and play a role in reducing pain and promoting feelings of well-being. Studies show that endorphin release can significantly alleviate stress and anxiety.
2. Substance P: This peptide is involved in pain perception and is also associated with inflammatory processes in the body.
3. Oxytocin: Often called the "love hormone," oxytocin plays a crucial role in social bonding, trust, and maternal behaviours. It's released during childbirth and breastfeeding, and also during positive social interactions.

Acetylcholine

Acetylcholine doesn't fit neatly into the above categories and is often considered in a class of its own.

1. Acetylcholine: This neurotransmitter is crucial for cognitive functions such as memory and learning. It's also the primary neurotransmitter of the parasympathetic nervous system, involved in slowing heart rate, constricting pupils, and stimulating digestion. Research indicates that acetylcholine levels can influence cognitive decline in ageing populations.

Each of these neurotransmitters plays multiple roles in the nervous system, often with different effects depending on the specific receptor they bind to and the area of the brain or body where the interaction occurs. The intricate balance and interplay between these various neurotransmitters form the basis of our complex cognitive, emotional, and physiological processes.

Neurotransmitter Disorders

Neurotransmitter disorders occur when there are imbalances or dysfunctions in the production, release, reception, or reuptake of neurotransmitters. These imbalances can lead to a wide range of mental health conditions and neurological disorders. Understanding these disorders is crucial for developing effective treatments and improving the quality of life for those affected.

Here's a list of common neurotransmitter disorders and their associated symptoms:

1. Depression  

• Symptoms: Persistent sadness, loss of interest in activities, changes in sleep and appetite, difficulty concentrating, feelings of worthlessness  
• Associated neurotransmitters: Primarily serotonin, but also norepinephrine and dopamine  

2. Anxiety Disorders

• Symptoms: Excessive worry, restlessness, difficulty concentrating, sleep disturbances, muscle tension  
• Associated neurotransmitters: GABA, serotonin, norepinephrine  

3. Bipolar Disorder 

• Symptoms: Alternating periods of depression and mania (elevated mood, increased energy, decreased need for sleep)  
• Associated neurotransmitters: Serotonin, dopamine, norepinephrine  

4. Schizophrenia  

• Symptoms: Hallucinations, delusions, disorganized thinking and speech, lack of motivation  
• Associated neurotransmitters: Dopamine, glutamate, GABA  

5. Attention Deficit Hyperactivity Disorder (ADHD)and   

• Symptoms: Difficulty focusing, hyperactivity, impulsivity  
• Associated neurotransmitters: Dopamine, norepinephrine  

6. Parkinson's Disease  

• Symptoms: Tremors, stiffness, slow movement, balance problems  
• Associated neurotransmitters: Primarily dopamine, but also acetylcholine and norepinephrine  

7. Alzheimer's Disease 

• Symptoms: Memory loss, confusion, difficulty with language and problem-solving
• Associated neurotransmitters: Acetylcholine, glutamate  

8. Obsessive-Compulsive Disorder (OCD)

• Symptoms: Recurring, intrusive thoughts (obsessions) and repetitive behaviours (compulsions)  
• Associated neurotransmitters: Serotonin, dopamine, glutamate  

9. Tourette Syndrome

• Symptoms: Motor and vocal tics  
• Associated neurotransmitters: Dopamine, serotonin, norepinephrine  

10. Addiction 

• Symptoms: Compulsive drug-seeking behaviour, inability to control substance use despite negative consequences  
• Associated neurotransmitters: Dopamine, serotonin, GABA, glutamate  

These disorders arise from complex interactions between genetic, environmental, and neurochemical factors. In many cases, the relationship between neurotransmitter imbalances and these conditions is not straightforward.

For instance, while depression is often associated with low serotonin levels, the reality is more complex, involving multiple neurotransmitter systems and neural circuits.

The impact of neurotransmitter disorders on mental and physical health can be profound. They can affect a person's mood, cognition, behaviour, and overall quality of life.

Many of these disorders are chronic, and require ongoing management and treatment. Treatment approaches for neurotransmitter disorders often involve medications that target specific neurotransmitter systems. 

For example:

• Selective Serotonin Reuptake Inhibitors (SSRIs) are commonly used to treat depression and anxiety disorders by increasing serotonin levels in the brain. 
• Dopamine agonists are used in the treatment of Parkinson's disease to compensate for the loss of dopamine-producing neurons. 
• Stimulant medications used to treat ADHD work by increasing dopamine and norepinephrine activity in the brain. 

However, medication is often just one part of a comprehensive treatment plan. Psychotherapy, lifestyle changes, and other interventions can also play crucial roles in managing these disorders. 

It's important to note that while neurotransmitter imbalances are associated with these disorders, the relationship is complex and not fully understood.

Mental health conditions are multifaceted, involving an interplay of biological, psychological, and environmental factors. Therefore, a holistic approach to treatment, addressing all these aspects, is often the most effective. 

With the advancement of research in neuroscience and psychiatry, our understanding of neurotransmitter disorders continues to evolve, leading to more targeted and effective treatments.

However, it's crucial for individuals experiencing symptoms of these disorders to seek professional medical advice for proper diagnosis and treatment, as self-diagnosis or self-treatment can be ineffective or even harmful.

Neurotransmitters vs. Neuromodulators

While neurotransmitters and neuromodulators are both crucial for neural communication, they have distinct characteristics and functions.

Understanding the differences between these two types of signalling molecules can provide valuable insights into the complexity of neural communication and the regulation of brain function.

Neurotransmitters are chemical messengers that transmit signals directly from one neuron to another across synapses. They typically act quickly and have relatively short-lived effects.

When a neurotransmitter is released from a presynaptic neuron, it crosses the synaptic cleft and binds to specific receptors on the postsynaptic neuron, causing an immediate change in the electrical properties of the target cell.

Neuromodulators, on the other hand, are substances that modify the effects of neurotransmitters. Neurons can release them but often originate from other sources as well, such as hormones from the endocrine system.

Neuromodulators typically have more diffuse and longer-lasting effects than neurotransmitters. They can influence multiple neurons simultaneously and alter the overall excitability of neural circuits.

Here's a table comparing excitatory, inhibitory, and modulatory neurotransmitters to help illustrate these differences:

Neurotransmitter Research and Future Directions

The field of neurotransmitter research is rapidly evolving, with novel discoveries constantly reshaping our understanding of brain function and opening up exciting possibilities for treating neurological and psychiatric disorders. Here are some key areas of current research and potential future directions:

1. Advanced Imaging Techniques: Researchers are developing increasingly sophisticated imaging technologies to visualize neurotransmitter activity in real time. Techniques like optogenetics allow scientists to control specific neurotransmitter systems with light, providing unprecedented insight into their roles in behaviour and cognition. Future advancements may allow for non-invasive monitoring of neurotransmitter levels in humans, leading to more precise diagnoses and treatment monitoring.
2. Personalized Medicine: There's growing interest in developing personalized treatments based on individual neurotransmitter profiles. Genetic testing and advanced brain imaging could potentially be used to tailor treatments to each patient's unique neurochemistry. This approach could significantly improve the efficacy of treatments for conditions like depression and anxiety, where current medications are not always effective for all patients.
3. Novel Drug Targets: Research is uncovering new subtypes of neurotransmitter receptors and transporters, providing potential targets for more specific and effective medications. For example, recent work on glutamate receptor subtypes has led to the development of ketamine-based treatments for treatment-resistant depression.
4. Gut-Brain Axis: Emerging research is exploring the connection between gut microbiota and neurotransmitter function. The gut produces many of the same neurotransmitters found in the brain, and there's growing evidence that the gut microbiome can influence mood and cognition. This could lead to novel probiotic or dietary interventions for mental health disorders.
5. Neurotransmitter-Based Biomarkers: Scientists are working to identify reliable biomarkers based on neurotransmitter function for various neurological and psychiatric disorders. These could potentially lead to earlier and more accurate diagnoses, as well as better ways to monitor treatment progress.
6. Neuromodulation Techniques: Advancements in neuromodulation techniques, such as transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS), are providing new ways to influence neurotransmitter systems non-invasively. Future refinements of these techniques could offer alternatives or supplements to pharmacological treatments.
7. Artificial Intelligence and Machine Learning: AI and machine learning are being applied to analyze complex neurotransmitter interactions and predict treatment outcomes. These tools could help in drug discovery, treatment optimization, and understanding the intricate relationships between different neurotransmitter systems.
8. Epigenetic Influences: Research is exploring how environmental factors and experiences can influence neurotransmitter function through epigenetic mechanisms. This could lead to new preventive strategies and treatments that target the underlying causes of neurotransmitter imbalances.
9. Nanoparticle Drug Delivery: Researchers are developing nanoparticle-based drug delivery systems that can target specific neurotransmitter systems more precisely. This could potentially reduce side effects and improve the efficacy of neuropsychiatric medications.
10. Neurotransmitter-Based Neural Interfaces: Advances in brain-computer interfaces may allow for direct modulation of neurotransmitter systems, potentially offering new treatments for conditions like paralysis or severe psychiatric disorders.
11. Neuroinflammation and Neurotransmitter Interaction: Research is increasingly focusing on the role of neuroinflammation in neurotransmitter function. Chronic inflammation in the brain may alter neurotransmitter signalling and contribute to various psychiatric disorders. Understanding this relationship could lead to new anti-inflammatory treatments that target neurotransmitter systems.
12. Psychedelic Research: The resurgence of interest in psychedelics for therapeutic use has opened a new frontier in neurotransmitter research. Substances like psilocybin and LSD have been shown to affect serotonin receptors and may promote neuroplasticity, offering potential treatments for depression and PTSD. Ongoing studies aim to elucidate the mechanisms through which these compounds affect neurotransmitter systems.
13. Neurotransmitter Modulation in Aging: As we age, neurotransmitter systems undergo changes that can impact cognitive function and emotional health. Research is exploring how to modulate these systems to mitigate age-related decline in mental health. This includes investigating the role of exercise, diet, and cognitive training in maintaining neurotransmitter balance in older adults.

These emerging areas of research hold great promise for advancing our understanding of neurotransmitters and developing new treatments for a wide range of neurological and psychiatric conditions.

However, it's important to note that much of this research is still in its early stages, and it may be years before some of these potential applications become clinical realities.

As research progresses, ethical considerations will also need to be carefully addressed, particularly in areas involving direct manipulation of brain function. Balancing the potential benefits of these new technologies with concerns about privacy, autonomy, and equitable access will be crucial as the field moves forward.

Despite these challenges, the future of neurotransmitter research is incredibly exciting. As our understanding of these crucial signalling molecules deepens, we move closer to more effective, personalized treatments for mental health disorders and a greater comprehension of the complex workings of the human brain.

Conclusion

Neurotransmitters are fundamental to maintaining brain health and overall well-being. Their roles in communication, mood regulation, cognition, and behaviour underscore their importance in mental health. Understanding neurotransmitters can guide effective treatments for various disorders, emphasizing the need for ongoing research in this critical area of neuroscience. Individuals experiencing symptoms related to neurotransmitter imbalances should seek professional medical advice for proper diagnosis and treatment, as self-diagnosis can be misleading and harmful. As research moves forward, our understanding of neurotransmitters and their impact on mental health will continue to evolve, leading to more targeted and effective interventions to improve overall brain health and well-being.

References

1. Acero, V. P., Cribas, E. S., Browne, K. D., Rivellini, O., Burrell, J. C., O’Donnell, J. C., Das, S., & Cullen, D. K. (2023). Bedside to bench: the outlook for psychedelic research. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1240295
2. Action potentials and synapses. (2023, April 26). Queensland Brain Institute - University of Queensland. https://qbi.uq.edu.au/brain-basics/brain/brain-physiology/action-potentials-and-synapses
3. Burrows, M. (1996). Neurotransmitters, neuromodulators and neurohormones Neurotransmitters, neuromodulators and neurohormones. In Oxford University Press eBooks (pp. 168–228). https://doi.org/10.1093/acprof:oso/9780198523444.003.0005
4. Cafasso, J. (2023, April 18). Chemical Imbalance in the Brain: What You Should Know. Healthline. https://www.healthline.com/health/chemical-imbalance-in-the-brain
5. Chen, Y., Xu, J., & Chen, Y. (2021b). Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients, 13(6), 2099. https://doi.org/10.3390/nu13062099
6. Chen, W., Li, C., Liang, W., Li, Y., Zou, Z., Xie, Y., Liao, Y., Yu, L., Lin, Q., Huang, M., Li, Z., & Zhu, X. (2022). The Roles of Optogenetics and Technology in Neurobiology: A Review. Frontiers in Aging Neuroscience, 14. https://doi.org/10.3389/fnagi.2022.867863
7. Dalangin, R., Kim, A., & Campbell, R. E. (2020). The Role of Amino Acids in Neurotransmission and Fluorescent Tools for Their Detection. International Journal of Molecular Sciences, 21(17), 6197. https://doi.org/10.3390/ijms21176197
8. Dfarhud, D., Malmir, M., & Khanahmadi, M. (2014, November 1). Happiness & Health: The Biological Factors- Systematic Review Article. PubMed Central (PMC). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449495/
9. D’Onofrio, V., Manzo, N., Guerra, A., Landi, A., Baro, V., Määttä, S., Weis, L., Porcaro, C., Corbetta, M., Antonini, A., & Ferreri, F. (2023). Combining Transcranial Magnetic Stimulation and Deep Brain Stimulation: Current Knowledge, Relevance and Future Perspectives. Brain Sciences, 13(2), 349. https://doi.org/10.3390/brainsci13020349
10. Frothingham, S. (2018, December 12). What Are Excitatory Neurotransmitters? Healthline. https://www.healthline.com/health/neurological-health/excitatory-neurotransmitters
11. García-Gutiérrez, M. S., Navarrete, F., Sala, F., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020). Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality. Frontiers in Psychiatry, 11. https://doi.org/10.3389/fpsyt.2020.00432
12. Goetz, L. H., & Schork, N. J. (2018). Personalized medicine: motivation, challenges, and progress. Fertility and Sterility, 109(6), 952–963. https://doi.org/10.1016/j.fertnstert.2018.05.006
13. Grezenko, H., Ekhator, C., Nwabugwu, N. U., Ganga, H., Affaf, M., Abdelaziz, A. M., Rehman, A., Shehryar, A., Abbasi, F. A., Bellegarde, S. B., & Khaliq, A. S. (2023). Epigenetics in Neurological and Psychiatric Disorders: A Comprehensive Review of Current Understanding and Future Perspectives. Cureus. https://doi.org/10.7759/cureus.43960
14. Jiang, Y., Zou, D., Li, Y., Gu, S., Dong, J., Ma, X., Xu, S., Wang, F., & Huang, J. H. (2022). Monoamine Neurotransmitters Control Basic Emotions and Affect Major Depressive Disorders. Pharmaceuticals, 15(10), 1203. https://doi.org/10.3390/ph15101203
15. Lovinger, D. M. (2008). Communication Networks in the Brain: Neurons, Receptors, Neurotransmitters, and Alcohol. PubMed Central (PMC). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860493/
16. Mave. (2024g, July 19). How Do Psychiatrists Treat ADHD in 2024. MAVE HEALTH PRIVATE LIMITED. https://www.mavehealth.com/blogs/how-do-psychiatrists-treat-adhd-attention-deficit-hyperactivity-disorder
17. Mave. (2024j, July 29). Selective Serotonin Reuptake Inhibitors[SSRIs]: Types, Uses, Drug, Side Effects, and How it Works. MAVE HEALTH PRIVATE LIMITED. https://www.mavehealth.com/blogs/ssri-types-drug-side-effects-selective-serotonin-reuptake-inhibitor
18. Megha. (2024a, July 11). How to Boost Serotonin Naturally: By 9 Foods & 10 Lifestyle Tips. MAVE HEALTH PRIVATE LIMITED. https://www.mavehealth.com/blogs/how-to-boost-serotonin-naturally-foods-lifestyle
19. Matubbar, S., & Sikder, T. (2024b). A Human Happy Brain Chemical Dopamine, Endorphins, Oxytocin & Serotonin. https://www.researchgate.net/publication/381011103
20. Olguín, H. J., Guzmán, D. C., García, E. H., & Mejía, G. B. (2016). The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2016, 1–13. https://doi.org/10.1155/2016/9730467
21. Poza, J., Pujol, M., Ortega-Albás, J., & Romero, O. (2022). Melatonin in sleep disorders. Neurología (English Edition), 37(7), 575–585. https://doi.org/10.1016/j.nrleng.2018.08.004
22. Professional, C. C. M. (2024g, June 27). Norepinephrine (Noradrenaline). Cleveland Clinic. https://my.clevelandclinic.org/health/articles/22610-norepinephrine-noradrenaline
23. Professional, C. C. M. (2024e, May 1). Endorphins. Cleveland Clinic. https://my.clevelandclinic.org/health/body/23040-endorphins
24. Professional, C. C. M. (2024a, May 1). Acetylcholine (ACh). Cleveland Clinic. https://my.clevelandclinic.org/health/articles/24568-acetylcholine-ach
25. Professional, C. C. M. (2024b, May 1). Neurotransmitters. Cleveland Clinic. https://my.clevelandclinic.org/health/articles/22513-neurotransmitters
26. Professional, C. C. M. (2024c, May 1). Dopamine Agonists. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/24958-dopamine-agonists
27. Professional, C. C. M. (2024b, May 1). ADHD Medication. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/11766-adhd-medication
28. Ranabir, S., & Reetu, K. (2011). Stress and hormones. Indian Journal of Endocrinology and Metabolism, 15(1), 18. https://doi.org/10.4103/2230-8210.77573
29. Remes, O., Mendes, J. F., & Templeton, P. (2021). Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature. Brain Sciences, 11(12), 1633. https://doi.org/10.3390/brainsci11121633
30. Rhie, S. J., Jung, E. Y., & Shim, I. (2020). The role of neuroinflammation on pathogenesis of affective disorders. Journal of Exercise Rehabilitation, 16(1), 2–9. https://doi.org/10.12965/jer.2040016.008
31. Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008). Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nature Reviews Drug Discovery, 7(5), 426–437. https://doi.org/10.1038/nrd2462
32. Savolainen, K. (2001). Understanding the Toxic Actions of Organophosphates. In Elsevier eBooks (pp. 1013–1041). https://doi.org/10.1016/b978-012426260-7.50053-7
33. Scaccia, A. (2024, July 3). Everything You Need to Know About Serotonin. Healthline. https://www.healthline.com/health/mental-health/serotonin
34. Schimelpfening, N. (2024, July 21). The Chemistry of Depression. Verywell Mind. https://www.verywellmind.com/the-chemistry-of-depression-1065137
35. Selective serotonin reuptake inhibitors (SSRIs). (2019, September 17). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/depression/in-depth/ssris/art-20044825
36. Siegel, J. M. (2004). The Neurotransmitters of Sleep. PubMed Central (PMC). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761080/
37. Shih, J. J., Krusienski, D. J., & Wolpaw, J. R. (2012). Brain-Computer Interfaces in Medicine. Mayo Clinic Proceedings, 87(3), 268–279. https://doi.org/10.1016/j.mayocp.2011.12.008
38. Teleanu, R. I., Niculescu, A. G., Roza, E., Vladâcenco, O., Grumezescu, A. M., & Teleanu, D. M. (2022). Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System. International Journal of Molecular Sciences, 23(11), 5954. https://doi.org/10.3390/ijms23115954
39. Triarhou, L. C. (2013). Dopamine and Parkinson’s Disease. Madame Curie Bioscience Database - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK6271/
40. Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. M., Jin, J., Zhou, M., & Zhang, B. (2020). Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions. Medicinal Research Reviews, 41(3), 1427–1473. https://doi.org/10.1002/med.21764
41. Zhou, Y., & Danbolt, N. C. (2014). Glutamate as a neurotransmitter in the healthy brain. Journal of Neural Transmission, 121(8), 799–817. https://doi.org/10.1007/s00702-014-1180-8
42. Zorkina, Y., Abramova, O., Ushakova, V., Morozova, A., Zubkov, E., Valikhov, M., Melnikov, P., Majouga, A., & Chekhonin, V. (2020). Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules, 25(22), 5294. https://doi.org/10.3390/molecules25225294
43. Feature Image Designed by - Freepik